Neogenomics (NEO) Cash from Operations Growth (5y) (2015 - 2026)
Neogenomics (NEO) Cash from Operations Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 74.88% |
| Mar 31, 2026 | -41.55% |
| Dec 31, 2025 | -25.83% |
| Sep 30, 2025 | 76.00% |
| Jun 30, 2025 | 60.95% |
| Mar 31, 2025 | -29.58% |
| Dec 31, 2024 | 23.88% |
| Sep 30, 2024 | -13.08% |
| Jun 30, 2024 | 37.65% |
| Mar 31, 2024 | -44.27% |
| Dec 31, 2023 | 2.85% |
| Sep 30, 2023 | -21.57% |
| Jun 30, 2023 | -17.43% |
| Mar 31, 2023 | -23.62% |
| Dec 31, 2022 | -21.43% |
| Sep 30, 2022 | -33.17% |
| Jun 30, 2022 | -35.71% |
| Mar 31, 2022 | -76.70% |
| Dec 31, 2021 | -141.45% |
| Sep 30, 2021 | -22.93% |